{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:15:51Z","timestamp":1787022951683,"version":"build-2736575974"},"reference-count":27,"publisher":"Akademiai Kiado Zrt.","issue":"7","funder":[{"name":"Nemzeti N\u00e9peg\u00e9szs\u00e9g\u00fcgyi K\u00f6zpont","award":["EFOP1.8.1-VEKOP-15-2016-00001"],"award-info":[{"award-number":["EFOP1.8.1-VEKOP-15-2016-00001"]}]}],"content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2025,2,16]]},"abstract":"\n Bevezet\u00e9s:<\/jats:italic>\n A hum\u00e1n papillomav\u00edrus kimutat\u00e1s\u00e1n alapul\u00f3\n hat\u00e9konyabb m\u00e9hnyaksz\u0171r\u00e9s hazai bevezet\u00e9s\u00e9nek tervez\u00e9sekor a szakorvoshoz nem\n vagy ritk\u00e1n eljut\u00f3 n\u0151k k\u00f6zvetlen megsz\u00f3l\u00edt\u00e1sa, el\u00e9r\u00e9se is fontos. A v\u00e9d\u0151n\u0151k\n k\u00e9pz\u00e9se k\u00f6zel egy \u00e9vtizede kieg\u00e9sz\u00fclt a n\u00e9peg\u00e9szs\u00e9g\u00fcgyi c\u00e9l\u00fa m\u00e9hnyaksz\u0171r\u00e9s\n kompetenci\u00e1j\u00e1val.\n C\u00e9lkit\u0171z\u00e9s:<\/jats:italic>\n Egy kor\u00e1bbi hazai reprezentat\u00edv\n hum\u00e1n papillomav\u00edrus prevalencia felm\u00e9r\u00e9s adatai alapj\u00e1n elemezt\u00fck a v\u00e9d\u0151n\u0151k\n \u00e1ltal el\u00e9rt popul\u00e1ci\u00f3 jellemz\u0151it \u00e9s az \u00e1ltaluk levett mint\u00e1k (n = 905)\n eredm\u00e9nyeit, \u00f6sszehasonl\u00edtva a szakorvosok \u00e1ltal sz\u0171rt popul\u00e1ci\u00f3val \u00e9s\n eredm\u00e9nyekkel (n = 3826).\n M\u00f3dszer:<\/jats:italic>\n Anonim k\u00e9rd\u0151\u00edves felm\u00e9r\u00e9st\n \u00e9s m\u00e9hnyaki mintav\u00e9telt v\u00e9gezt\u00fcnk megy\u00e9nk\u00e9nt v\u00e9letlenszer\u0171en kiv\u00e1lasztott,\n \u00f6sszesen 169 sz\u00fcl\u00e9sz-n\u0151gy\u00f3gy\u00e1sz szakorvos \u00e9s 40 v\u00e9d\u0151n\u0151 seg\u00edts\u00e9g\u00e9vel ThinPrep\n ed\u00e9nyzetbe Rovers Cervex-Brush Combi eszk\u00f6zzel. A laborat\u00f3riumi feldolgoz\u00e1s\n Neumann Confidence \u00e9s Roche Linear Array klinikailag valid\u00e1lt genotipiz\u00e1l\u00f3\n tesztekkel t\u00f6rt\u00e9nt.\n Eredm\u00e9nyek:<\/jats:italic>\n A v\u00e9d\u0151n\u0151i sz\u0171r\u00e9sen r\u00e9szt vettek\n k\u00f6r\u00e9ben a p\u00e1ciensek \u00e1tlag\u00e9letkora, az \u00e9retts\u00e9givel nem rendelkez\u0151k \u00e9s azok\n ar\u00e1nya, akikn\u00e9l 3 \u00e9vn\u00e9l r\u00e9gebben vagy soha nem t\u00f6rt\u00e9nt kenetcitol\u00f3giai\n m\u00e9hnyaksz\u0171r\u00e9s, szignifik\u00e1nsan magasabb volt, mint a szakorvosi sz\u0171r\u00e9sen r\u00e9szt\n vev\u0151k k\u00f6r\u00e9ben. Az 55 \u00e9v feletti korcsoportokban a v\u00e9d\u0151n\u0151k mint\u00e1ja l\u00e9nyegesen\n k\u00f6zelebb \u00e1llt a c\u00e9lcsoport popul\u00e1ci\u00f3s r\u00e9szar\u00e1ny\u00e1hoz, mint a szakorvosokn\u00e1l\n megjelentek\u00e9. Az eredm\u00e9nytelen mint\u00e1k ar\u00e1nya nem t\u00e9rt el szignifik\u00e1nsan att\u00f3l\n f\u00fcgg\u0151en, hogy v\u00e9d\u0151n\u0151 vagy szakorvos vette a mint\u00e1t. A szakorvosok p\u00e1ciensein\u00e9l a\n pozitivit\u00e1si ar\u00e1ny szignifik\u00e1nsan nagyobb volt, b\u00e1r nagyobb ar\u00e1nyban kaptak\n kor\u00e1bban hum\u00e1n papillomav\u00edrus elleni v\u00e9d\u0151olt\u00e1st.\n Megbesz\u00e9l\u00e9s:<\/jats:italic>\n A\n k\u00f6zs\u00e9gi mint\u00e1kban az \u00e9letkori hat\u00e1s statisztikai kik\u00fcsz\u00f6b\u00f6l\u00e9se ut\u00e1n is l\u00e1tott\n alacsonyabb v\u00edrusprevalenci\u00e1nak medi\u00e1tora lehetett a mintav\u00e9telt v\u00e9gz\u0151 szakember\n is, hiszen k\u00f3ros el\u0151zm\u00e9nyekkel rendelkez\u0151 p\u00e1ciens nagyobb es\u00e9llyel fordulhat\n szakorvoshoz, mintsem hogy megv\u00e1rja a v\u00e9d\u0151n\u0151i megkeres\u00e9st.\n K\u00f6vetkeztet\u00e9s:<\/jats:italic>\n Az iskolai olt\u00e1si program elindul\u00e1s\u00e1t,\n valamint a m\u00e9hnyakr\u00e1k el\u0151fordul\u00e1s\u00e1nak koroszt\u00e1lyi eloszl\u00e1s\u00e1t figyelembe v\u00e9ve a\n sz\u0171r\u00e9s szerepe sikeres olt\u00e1si program mellett is legal\u00e1bb 20\u201330 \u00e9vig jelent\u0151s\n marad. Az 50 \u00e9v feletti, k\u00f6zs\u00e9gben \u00e9l\u0151, alacsonyabb iskol\u00e1zotts\u00e1g\u00fa c\u00e9lcsoport\n bevon\u00e1sa v\u00e9d\u0151n\u0151k\u00f6n kereszt\u00fcl hat\u00e9konyabbnak bizonyult, mint szakorvosi\n rendel\u00e9sen. Az erre k\u00e9pzett v\u00e9d\u0151n\u0151k bizony\u00edtottan eredm\u00e9nyes mintav\u00e9tellel, a\n n\u0151k egy\u00e9ni felkeres\u00e9s\u00e9vel, a sz\u0171r\u00e9ssel kapcsolatos k\u00e9ts\u00e9geik megv\u00e1laszol\u00e1s\u00e1val\n egyed\u00fcl\u00e1ll\u00f3 szerepet j\u00e1tszhatnak a prevenci\u00f3s c\u00e9lok megval\u00f3sul\u00e1s\u00e1ban. Orv Hetil.\n 2025; 166(7): 263\u2013271.\n <\/jats:p>","DOI":"10.1556\/650.2025.33233","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T04:01:25Z","timestamp":1739678485000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":2,"title":["Az alapell\u00e1t\u00e1s szerepe a n\u00e9peg\u00e9szs\u00e9g\u00fcgyi m\u00e9hnyaksz\u0171r\u00e9sben"],"prefix":"10.1556","volume":"166","author":[{"given":"Istv\u00e1n Andr\u00e1s","family":"Fogarasi","sequence":"first","affiliation":[{"name":"SYNLAB Budapest Diagnosztikai K\u00f6zpont, GenoID Molekul\u00e1ris Diagnosztikai Laborat\u00f3rium Budapest, Baradla u. 5., 1112 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Melczer","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Sz\u00fcl\u00e9szeti \u00e9s N\u0151gy\u00f3gy\u00e1szati Klinika Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"Gyulai","sequence":"additional","affiliation":[{"name":"Miskolci Egyetem, Eg\u00e9szs\u00e9gtudom\u00e1nyi Kar, Alkalmazott Eg\u00e9szs\u00e9gtudom\u00e1nyok Int\u00e9zete, Prevent\u00edv Eg\u00e9szs\u00e9gtudom\u00e1nyi Int\u00e9zeti Tansz\u00e9k Miskolc Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"R1","unstructured":"World Health Organization. Web Annex A: Syntheses of evidence. In:\n WHO guideline for screening and treatment of cervical pre-cancer lesions for\n cervical cancer prevention, second edition. 2021, Geneva. Licence: CC BY-NC-SA\n 3.0 IGO. Available from:\n https:\/\/iris.who.int\/bitstream\/handle\/10665\/342366\/9789240030886-eng.pdf\n [accessed: Sept 16, 2024]."},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, et al. Efficacy of HPV-based\n screening for prevention of invasive cervical cancer: follow-up of four European\n randomised controlled trials. Lancet 2014; 383(9916): 524\u2013532. Erratum: Lancet.\n 2015; 386(10002):1446.","DOI":"10.1016\/S0140-6736(13)62218-7"},{"key":"R3","unstructured":"European Commission. Proposal for a Council Recommendation on\n strengthening prevention through early detection: a new EU approach on cancer\n screening replacing Council Recommendation 2003\/878\/EC. Brussels, 2022.\n Available from:\n https:\/\/health.ec.europa.eu\/system\/files\/2022-09\/com_2022-474_act_en.pdf\n [accessed: Sept 16, 2024]."},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Koiss R, Boncz I, Hern\u00e1di Z, et al. Proposal for the modernization\n of cervical screening procedure in Hungary. [Javaslat a hazai m\u00e9hnyaksz\u0171r\u00e9si\n elj\u00e1r\u00e1srend korszer\u0171s\u00edt\u00e9s\u00e9re.] Orv Hetil. 2017; 158: 2062\u20132067.\n [Hungarian]","DOI":"10.1556\/650.2017.30896"},{"key":"R5","unstructured":"P\u00f3ka R. Cervical screening. International overview and proposal for\n the development of domestic guidelines. [M\u00e9hnyaksz\u0171r\u00e9s. Nemzetk\u00f6zi k\u00f6rk\u00e9p \u00e9s\n javaslat a hazai ir\u00e1nyelvek fejleszt\u00e9s\u00e9re.] Magy N\u0151orv L. 2018; 81: 38\u201346.\n [Hungarian]"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"McMenamin M, McKenna M, McDowell A. Clinical utility of CINTEC plus\n triage in equivocal cervical cytology and human papillomavirus primary\n screening. Am J Clin Pathol. 2018; 150: 512\u2013521.","DOI":"10.1093\/ajcp\/aqy073"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Kocsis A, Tak\u00e1cs T, Jeney C, et al. Performance of a new HPV and\n biomarker assay in the management of hrHPV positive women: subanalysis of the\n ongoing multicenter TRACE clinical trial (n\u2009>\u20096,000) to evaluate POU4F3\n methylation as a potential biomarker of cervical precancer and cancer. Int J\n Cancer 2017; 140: 1119\u20131133.","DOI":"10.1002\/ijc.30534"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Rurik I. How can the Swiss contribution improve Hungarian primary\n care. Primary Care 2014; 14: 155\u2013156.","DOI":"10.4414\/pc-d.2014.00460"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"S\u00e1ndor J, K\u00f3sa K, F\u00fcrjes G, et al. Public health services provided\n in the framework of general practitioners\u2019 clusters. Eur J Pub Health 2013; 23:\n 530\u2013532.","DOI":"10.1093\/eurpub\/ckt096"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Sawicki OA, Mueller A, Klaa\u00dfen-Mielke R, et al. Strong and\n sustainable primary healthcare is associated with a lower risk of\n hospitalization in high risk patients. Sci Rep. 2021; 11: 4349.","DOI":"10.1038\/s41598-021-83962-y"},{"key":"R11","unstructured":"World Health Organization. Primary Health Care. Report of the\n International Conference on Primary Health Care. Alma-Ata, USSR, 6\u201312 September\n 1978 Geneva, 1978. Available from:\n https:\/\/iris.who.int\/bitstream\/handle\/10665\/39228\/9241800011.pdf?sequence=1\n [accessed: Oct 8, 2024]."},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Elfstrom KM, Arnheim-Dahlstrom L, Von Karsa L, et al. Cervical\n cancer screening in Europe: quality assurance and organisation of programmes.\n Eur J Cancer 2015; 51: 950\u2013968.","DOI":"10.1016\/j.ejca.2015.03.008"},{"key":"R13","unstructured":"Ministry of Human Resources. Decree 28\/2013 (IV. 5.) amending Decree\n 49\/2004 (V. 21.) of the ESzCsM on the provision of regional care by a health\n visitors [28\/2013. (IV. 5.) EMMI rendelet a ter\u00fcleti v\u00e9d\u0151n\u0151i ell\u00e1t\u00e1sr\u00f3l sz\u00f3l\u00f3\n 49\/2004. (V. 21.) ESzCsM rendelet m\u00f3dos\u00edt\u00e1s\u00e1r\u00f3l]. Available from:\n http:\/\/www.hbcs.hu\/uploads\/jogszabaly\/1509\/fajlok\/28_2013_emmir.pdf\n [accessed: July 17, 2024]. [Hungarian]"},{"key":"R14","unstructured":"Ministry of Human Resources. Decree 18\/2016 (VIII.5.) amending EMMI\n Decree 8\/2013 (I. 30.) on the training and outcome requirements of higher\n education vocational training, bachelor\u2019s and master\u2019s programs, common\n requirements for teacher preparation and the training and outcome requirements\n of certain teacher specializations. [18\/2016. (VIII. 5.) EMMI rendelet a\n fels\u0151oktat\u00e1si szakk\u00e9pz\u00e9sek, az alap- \u00e9s mesterk\u00e9pz\u00e9sek k\u00e9pz\u00e9si \u00e9s kimeneti\n k\u00f6vetelm\u00e9nyeir\u0151l, valamint a tan\u00e1ri felk\u00e9sz\u00edt\u00e9s k\u00f6z\u00f6s k\u00f6vetelm\u00e9nyeir\u0151l \u00e9s az\n egyes tan\u00e1rszakok k\u00e9pz\u00e9si \u00e9s kimeneti k\u00f6vetelm\u00e9nyeir\u0151l sz\u00f3l\u00f3 8\/2013. (I. 30.)\n EMMI rendelet m\u00f3dos\u00edt\u00e1s\u00e1r\u00f3l.] Magy K\u00f6zl. 2016; 116: 10408\u201311971.\n [Hungarian]"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Gyulai A, Tak\u00e1cs P, S\u00e1rv\u00e1ry A, et al. Survey of the professional\n attitude of health visitors involved in cervical screening for public health\n purposes. [A n\u00e9peg\u00e9szs\u00e9gu\u0308gyi c\u00e9l\u00fa m\u00e9hnyaksz\u0171r\u00e9sben r\u00e9szt vev\u0151 v\u00e9d\u0151n\u0151k szakmai\n attit\u0171dj\u00e9nek vizsg\u00e1lata.] AranyPajzs 2022; 1: 6\u201323. [Hungarian]","DOI":"10.56077\/AP.2022.2.1"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Fogarasi AI, Benczik M, Moravcsik-Kornyicki \u00c1, et al. The prevalence\n of high-risk human papillomavirus in Hungary. A geographically representative,\n cross-sectional study. Pathol Oncol Res. 2022; 28: 1610424.","DOI":"10.3389\/pore.2022.1610424"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Act CLXXXIX of 2011 on local governments in Hungary. [2011. \u00e9vi\n CLXXXIX. t\u00f6rv\u00e9ny Magyarorsz\u00e1g helyi \u00f6nkorm\u00e1nyzatair\u00f3l.] Available from:\n https:\/\/njt.hu\/jogszabaly\/2011-189-00-00.8 [accessed: July 17,\n 2024]. [Hungarian]","DOI":"10.1055\/s-0032-1322433"},{"key":"R18","unstructured":"Census database \u2013 Hungarian Central Statistical Office. [Available\n from: www.ksh.hu [accessed: July 17, 2024]. [Hungarian]"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Walji LT, Murchie P, Lip G, et al. Exploring the influence of rural\n residence on uptake of organized cancer screening \u2013 a systematic review of\n international literature. Cancer Epidemiol. 2021; 74: 101995.","DOI":"10.1016\/j.canep.2021.101995"},{"key":"R20","unstructured":"National Cancer Registry and Biostatistics Centre. [Nemzeti\n R\u00e1kregiszter \u00e9s Biostatisztikai K\u00f6zpont.] Available from:\n https:\/\/onkol.hu\/nemzeti-rakregiszter-es-biostatisztikai-kozpont\/\n [accessed: July 17, 2024]. [Hungarian]"},{"key":"R21","unstructured":"European Commission. Anttila A, Arbyn M, De Vuyst H, et al. (eds).\n European guidelines for quality assurance in cervical cancer screening. Second\n edition: supplements. Publications Office of the European Union, Luxembourg,\n 2015."},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Nothacker J, Nury E, Roebl Mathieu M, et al. Women\u2019s attitudes\n towards a human papillomavirus-based cervical cancer screening strategy: a\n systematic review. BMJ Sex Reprod Health 2022; 48: 295\u2013306.","DOI":"10.1136\/bmjsrh-2022-201515"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Boncz I, Sebesty\u00e9n A, D\u00f6br\u0151ssy L, et al. The coverage of cervical\n screening in Hungary. [A m\u00e9hnyaksz\u0171r\u00e9s r\u00e9szv\u00e9teli mutat\u00f3i Magyarorsz\u00e1gon.] Orv\n Hetil. 2007; 148: 2177\u20132182. [Hungarian]","DOI":"10.1556\/oh.2007.28956"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Chorley AJ, Marlow LA, Forster AS, et al. Experiences of cervical\n screening and barriers to participation in the context of an organised\n programme: a systematic review and thematic synthesis. Psychooncology 2017; 26:\n 161\u2013172.","DOI":"10.1002\/pon.4126"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"M\u00f3zes N, Feith HJ. Comparative study of factors influencing\n cytological screening for cervical cancer attendance in Hungary among Roma and\n non-Roma population, in relation to Slovak and Romanian results. [A m\u00e9hnyakr\u00e1k\n citol\u00f3giai sz\u0171r\u0151vizsg\u00e1laton val\u00f3 r\u00e9szv\u00e9telt befoly\u00e1sol\u00f3 t\u00e9nyez\u0151k \u00f6sszehasonl\u00edt\u00f3\n felm\u00e9r\u00e9se Magyarorsz\u00e1gon roma \u00e9s nem roma lakoss\u00e1g k\u00f6r\u00e9ben, \u00f6sszef\u00fcgg\u00e9sben\n szlov\u00e1k \u00e9s rom\u00e1n eredm\u00e9nyekkel.] Orv Hetil. 2023; 164: 1416\u20131425.\n [Hungarian]","DOI":"10.1556\/650.2023.32842"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Kar\u00e1csony I, Bert\u00f3kn\u00e9 Tam\u00e1s R, \u00c1rv\u00e1n\u00e9 Egri Cs, et al. Summary of the\n Hungarian Mobile Health Screening Program data for 2021. [A \u201eHelybe vissz\u00fck a\n sz\u0171r\u0151vizsg\u00e1latokat\u201d program 2021. \u00e9vi adatainak \u00f6sszegz\u00e9se.] Orv Hetil. 2023;\n 164: 1070\u20131076. [Hungarian]","DOI":"10.1556\/650.2023.32763"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Sandberg T, Conner M. A mere measurement effect for anticipated\n regret: impacts on cervical screening attendance. Br J Soc Psychol. 2009; 48:\n 221\u2013236.","DOI":"10.1348\/014466608X347001"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/7\/article-p263.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/7\/article-p263.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/7\/article-p263.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:23:38Z","timestamp":1785497018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/7\/article-p263.xml"}},"subtitle":["K\u00f6vetkeztet\u00e9sek egy hazai nagy kock\u00e1zat\u00fa hum\u00e1n papillomav\u00edrus\n prevalencia felm\u00e9r\u00e9s adataib\u00f3l"],"short-title":[],"issued":{"date-parts":[[2025,2,16]]},"references-count":27,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1556\/650.2025.33233","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,16]]}}}